Market Size of Bovine Tuberculosis Diagnosis Industry
Study Period | 2021 - 2029 |
Base Year For Estimation | 2023 |
Forecast Data Period | 2024 - 2029 |
CAGR | 4.20 % |
Fastest Growing Market | Asia-Pacific |
Largest Market | North America |
Major Players*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Bovine Tuberculosis Diagnosis Market Analysis
The bovine tuberculosis diagnosis market is expected to register a CAGR of 4.2% over the forecast period.
The COVID-19 pandemic had a substantial impact on the bovine tuberculosis diagnosis market. Lockdown declarations in several nations, as well as the corresponding limited access to and closure of veterinary facilities, are mostly responsible for declining market growth. Due to the forced cancellation and reduction of veterinarian appointments, the pandemic made it harder for pet owners to receive proper veterinary diagnosis and treatment. For instance, according to a February 2022 article released by the Taylor & Francis Group, at the onset of the pandemic, around 70% of veterinary clinics in Canada and the United States closed their doors to the public to curb the spread of the virus to veterinary personnel as well as nonhuman animal patients in the clinic. However, the government and market players have taken various initiatives to continue their eradication programs during the pandemic. For instance, according to the Michigan Department of Agriculture and Rural Development (MDARD), activities under the Bovine Tuberculosis Eradication Program, such as TB testing, continued during the pandemic while following precautions to curb disease spread.
Furthermore, the increasing cattle population, coupled with increasing consumption of animal products, the increasing prevalence of zoonotic diseases, and supportive regulations and programs implemented by governments, are the factors driving the growth of the bovine tuberculosis diagnostics market over the forecast period.
Supportive regulations and programs implemented by governments are major factors driving the demand for the bovine tuberculosis diagnosis market. For instance, in May 2021, the United Kingdom's Department of Environment, Food, and Rural Affairs launched a proposal to help eradicate bovine tuberculosis in England through strategic priorities for a secure, productive, and sustainable agriculture system, a productive and sustainable food and drink industry, enhanced animal health and welfare, and plant health, as well as the government's overarching objective of supporting economic growth.
Moreover, the increasing prevalence of zoonotic diseases is also one of the factors driving the bovine tuberculosis diagnosis market. For example, the World Health Organization stated in May 2021 that identifying capacity gaps as well as agreement on good practices to prevent and prepare for zoonotic outbreaks, and the Food and Agriculture Organization of the United Nations and the World Organization for Animal Health had launched a guide for countries on taking a one-health approach to addressing zoonotic diseases.
In addition, new launches and strategic activities by major players in the market are positively affecting the growth of the studied market. For Instance, In February 2020, IDVET launched a new bovine tuberculosis qPCR test. It amplifies a target sequence in the Mycobacterium tuberculosis complex's genome (MTC). It is a qualitative duplex test that amplifies both the target DNA and an external internal control at the same time. It may be used to test lymph nodes and peripheral tissues from cattle, sheep, goats, deer, and badgers. Therefore, owing to the aforementioned factors, it is anticipated that the studied market will witness growth over the analysis period.
Bovine Tuberculosis Diagnosis Industry Segmentation
As per the scope of the report, bovine tuberculosis is an infectious disease of cattle. It is caused by the bacterium Mycobacterium bovis (M. bovis), which can also infect and cause disease in many other mammals, including humans, deer, goats, pigs, cats, dogs, and badgers. The bovine tuberculosis diagnosis market is segmented by test type (serological tests, molecular diagnostic tests, and traditional tests) and geography (North America, Europe, Asia-Pacific, the Middle East, Africa, and South America). The report offers the value (in USD million) for the above segments.
By Test Type | |
Serological Tests | |
Molecular Diagnostic Tests | |
Traditional Tests |
Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Bovine Tuberculosis Diagnosis Market Size Summary
The bovine tuberculosis diagnosis market is poised for growth, driven by several key factors including an increasing cattle population, rising consumption of animal products, and the prevalence of zoonotic diseases. Government initiatives and supportive regulations play a crucial role in this expansion, with countries like the United Kingdom implementing strategic priorities to eradicate bovine tuberculosis. The market has also seen advancements in molecular diagnostics, which offer faster and more efficient testing methods compared to traditional culture methods. These technological advancements, along with new product launches and strategic collaborations, are expected to significantly contribute to the market's growth over the forecast period.
North America is a prominent region in the bovine tuberculosis diagnosis market, attributed to the presence of major players, extensive research activities, and a high number of qualified veterinary clinics. The region's market growth is further supported by strategic initiatives from both government and private sectors, aimed at controlling and eradicating bovine tuberculosis. The competitive landscape of the market is characterized by strategic pricing, partnerships, and product expansions by leading companies such as IDEXX Laboratories, Zoetis, and Thermo Fisher Scientific Inc. These efforts, combined with ongoing research and development activities, are anticipated to drive the market forward, with a focus on enhancing diagnostic capabilities and addressing the challenges posed by bovine tuberculosis.
Bovine Tuberculosis Diagnosis Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Increasing Cattle Population Coupled with Increasing Consumption of Animal Products
-
1.2.2 Increasing Prevalence of Zoonotic Diseases
-
1.2.3 Supportive Regulations and Programs Implemented by Governments
-
-
1.3 Market Restraints
-
1.3.1 Restricted Access to Veterinary Services.
-
-
1.4 Porter's Five Forces Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION
-
2.1 By Test Type
-
2.1.1 Serological Tests
-
2.1.2 Molecular Diagnostic Tests
-
2.1.3 Traditional Tests
-
-
2.2 Geography
-
2.2.1 North America
-
2.2.1.1 United States
-
2.2.1.2 Canada
-
2.2.1.3 Mexico
-
-
2.2.2 Europe
-
2.2.2.1 Germany
-
2.2.2.2 United Kingdom
-
2.2.2.3 France
-
2.2.2.4 Italy
-
2.2.2.5 Spain
-
2.2.2.6 Rest of Europe
-
-
2.2.3 Asia-Pacific
-
2.2.3.1 China
-
2.2.3.2 Japan
-
2.2.3.3 India
-
2.2.3.4 Australia
-
2.2.3.5 South Korea
-
2.2.3.6 Rest of Asia-Pacific
-
-
2.2.4 Middle-East and Africa
-
2.2.4.1 GCC
-
2.2.4.2 South Africa
-
2.2.4.3 Rest of Middle East and Africa
-
-
2.2.5 South America
-
2.2.5.1 Brazil
-
2.2.5.2 Argentina
-
2.2.5.3 Rest of South America
-
-
-
Bovine Tuberculosis Diagnosis Market Size FAQs
What is the current Bovine Tuberculosis Diagnosis Market size?
The Bovine Tuberculosis Diagnosis Market is projected to register a CAGR of 4.20% during the forecast period (2024-2029)
Who are the key players in Bovine Tuberculosis Diagnosis Market?
IDEXX , PBD Biotech, Abbott, Zoetis and Thermo fisher scientific inc are the major companies operating in the Bovine Tuberculosis Diagnosis Market.